Eli Hazum

Eli Hazum

Teknisk/Vetenskaplig/F&U Direktör på
Medica Venture Partners
78 år
Health Technology
Consumer Services
Finance

Profil

Eli Hazum is currently General Partner, Partner, and CSO at Medica Venture Partners since 1995.
Former roles include Chief Executive Officer at Regentis Biomaterials Ltd. from 2021 to 2025, Chief Executive Officer at Ester Neurosciences Ltd., Chief Executive Officer and Director at Collgard Biopharmaceuticals Ltd., Director and Chief Technology Officer at PRF Technologies Ltd. from 2020 to 2025, Vice President-Research & Development at Peptor Ltd, Principal at Biotechnology General (Israel) Ltd., Head-Receptor Research & Metabolic Diseases at Research Triangle Foundation, and Head-Receptor Research & Metabolic Diseases at Glaxo, Inc. from 1988 to 1992.
Education includes undergraduate and graduate degrees from Tel-Aviv University, a doctorate from Weizmann Institute of Science conferred in 1978, and an MBA from Humberside University.

Aktiva positioner av Eli Hazum

FöretagPositionStart
Teknisk/Vetenskaplig/F&U Direktör 1995-01-01

Tidigare kända positioner av Eli Hazum

FöretagPositionSlut
REGENTIS BIOMATERIALS LTD. Verkställande Direktör 2025-12-31
PRF TECHNOLOGIES LTD. Verkställande Direktör 2020-11-23
Glaxo, Inc.
Företagsledare/Principal 1992-01-01
Företagsledare/Principal -
Företagsledare/Principal -
Se detaljerna i Eli Hazums erfarenhet

Eli Hazums utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

22

Första gradens relationer

12

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag12

Health Technology

Consumer Services

Finance

Consumer Services

Commercial Services

Health Technology

Health Technology

Glaxo, Inc.

Health Technology

Health Technology

Health Technology

Consumer Services